NCT00656188View on ClinicalTrials.gov

Placebo-controlled Study Evaluating the Efficacy and Safety of Vardenafil in Subjects With Erectile Dysfunction

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

463

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Erectile Dysfunction
Interventions
DRUG

Levitra (Vardenafil, BAY38-9456)

Vardenafil 5mg or 10mg or 20mg taken orally on demand 1 hour prior to sexual intercourse

DRUG

Placebo

Matching placebo

Sponsors

Lead Sponsor

Bayer

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

GlaxoSmithKline

INDUSTRY

lead

Bayer

INDUSTRY